Regeneron Pharmaceuticals Up Over 9%, on Pace for Largest Percent Increase Since November 2016 -- Data Talk

Regeneron Pharmaceuticals, Inc. (REGN) is currently at $341.12, up $30.08 or 9.67%

-- Would be highest close since May 6, 2019, when it closed at $344.23

-- On pace for largest percent increase since Nov. 9, 2016, when it rose 13.77%

-- Earlier Tuesday, Regeneron Pharmaceuticals Inc. said its board authorized the repurchase of up to $1 billion of common stock

-- The pharmaceutical company reported a third-quarter profit of $669.6 million, or $5.86 a share, compared with $594.7 million, or $5.17 a share, a year ago

-- Currently up 10 of the past 11 days

-- Currently up three consecutive days; up 11.37% over this period

-- Best three day stretch since the three days ending June 22, 2017, when it rose 11.63%

-- Down 8.67% year-to-date; on pace for worst year since 2016, when it fell 32.38%

-- Down 42.42% from its all-time closing high of $592.40 on Aug. 5, 2015

-- Traded as high as $344.10; highest intraday level since May 6, 2019, when it hit $344.92

-- Up 10.63% at today's intraday high; largest intraday percent increase since Nov. 9, 2016, when it rose as much as 14.33%

-- Second best performer in the S&P 500 today

-- Best performer in the Nasdaq 100 today

All data as of 12:54:25 PM

Source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

November 05, 2019 13:14 ET (18:14 GMT)

Copyright (c) 2019 Dow Jones & Company, Inc.